43 participants
Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-13
- Start Date:
- 2018-05-08
- Completion:
- 2021-05-24
Conditions
- Carcinoma, Non-Small-Cell Lung
Interventions
- BIOLOGICAL
- DRUG